Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells (Q40653427)

22 September 2017

title

Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells (English)

1 reference

22 September 2017

0 references

7

Daniel Tsun-Yee Chiu

1 reference

22 September 2017

Ching-Ping Tseng

1

1 reference

22 September 2017

Chien-Ling Huang

2

1 reference

22 September 2017

Ching-Hui Huang

3

1 reference

22 September 2017

Ju-Chien Cheng

4

1 reference

22 September 2017

Arnold Stern

5

1 reference

22 September 2017

Chin-Hsiao Tseng

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

541

1 reference

22 September 2017

issue

1-3

1 reference

22 September 2017

page(s)

21-27

1 reference

The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

DOC-2/DAB2 is the binding partner of myosin VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Differential inhibition by alpha- and beta-tocopherol of human erythroleukemia cell adhesion: role of integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

Herbimycin A inhibits phorbol ester-induced morphologic changes, adhesion, and megakaryocytic differentiation of the leukemia cell line, MEG-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900281-3

10.1016/S0014-5793(03)00281-3

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference